Disproportionate increase in prevalence of diabetes among patients with congestive heart failure due to systolic dysfunction

被引:16
作者
Kamalesh, M [1 ]
Nair, G [1 ]
机构
[1] Indiana Univ, Sch Med, Vet Adm Med Ctr, Krannert Inst Cardiol, Indianapolis, IN 46202 USA
关键词
diabetes; congestive heart failure; prevalence;
D O I
10.1016/j.ijcard.2004.05.049
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Despite new therapies, the prevalence of heart failure continues to escalate. The prevalence of diabetes, a risk factor for heart failure, also continues to rise. To further understand the increasing prevalence of heart failure, we compared trends in the prevalence of diabetes among individuals with diagnosed heart failure versus those in the general population. Methods: Fourteen randomized trials between 1989 and 1999 including subjects with heart failure (n = 34,633) were reviewed. For each trial, the enrollment date was used to estimate the yearly prevalence of diabetes among study participants with heart failure. The prevalence of diabetes in the general population was estimated based on United State's Center for Disease Control statistics from 1989 to 1999. The prevalence of diabetes between heart failure subjects and the general population was compared using a two-sample t-test for independent samples with unequal variances. Results: The prevalence of diabetes increased from 2.6% to 4.0% from 1989 to 1999 in the general U.S. population. Among patients with heart failure, the prevalence of diabetes increased from 13% to 47%. Diabetes prevalence estimates varied significantly (p < 0.001) between the general population and individuals with heart failure during the study period. Conclusions: The rising prevalence of diabetes may partially explain the growing epidemic of heart failure. Increased efforts targeting diabetes and other cardiovascular risk factors are warranted in attenuating the rising prevalence of heart failure. (c) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:125 / 127
页数:3
相关论文
共 25 条
[1]  
*AM HEART ASS, 2001, 2002 HEART STROK STA
[2]   Incidence of heart failure in 2,737 older persons with and without diabetes mellitus [J].
Aronow, WS ;
Ahn, C .
CHEST, 1999, 115 (03) :867-868
[3]   Heart failure - The frequent, forgotten, and often fatal complication of diabetes [J].
Bell, DSH .
DIABETES CARE, 2003, 26 (08) :2433-2441
[4]   Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril - V-HeFT III [J].
Cohn, JN ;
Ziesche, S ;
Smith, R ;
Anand, I ;
Dunkman, WB ;
Loeb, H ;
Cintron, G ;
Boden, W ;
Baruch, L ;
Rochin, P ;
Loss, L .
CIRCULATION, 1997, 96 (03) :856-863
[5]   A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure [J].
Cohn, JN ;
Tognoni, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23) :1667-1675
[6]   Short-term intravenous milrinone for acute exacerbation of chronic heart failure - A randomized controlled trial [J].
Cuffe, MS ;
Califf, RM ;
Adams, KF ;
Benza, R ;
Bourge, R ;
Colucci, WS ;
Massie, BM ;
O'Connor, CM ;
Pina, I ;
Quigg, R ;
Silver, MA ;
Georghiade, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (12) :1541-1547
[7]   RANDOMIZED TRIAL OF LOW-DOSE AMIODARONE IN SEVERE CONGESTIVE-HEART-FAILURE [J].
DOVAL, HC ;
NUL, DR ;
GRANCELLI, HO ;
PERRONE, SV ;
BORTMAN, GR ;
CURIEL, R .
LANCET, 1994, 344 (8921) :493-498
[8]  
Eichhorn E, 2001, NEW ENGL J MED, V344, P1659
[9]   Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure [J].
Hampton, JR ;
vanVeldhuisen, DJ ;
Kleber, FX ;
Cowley, AJ ;
Ardia, A ;
Block, P ;
Cortina, A ;
Cserhalmi, L ;
Follath, F ;
Jensen, G ;
Kayanakis, J ;
Lie, KI ;
Mancia, G ;
Skene, AM .
LANCET, 1997, 349 (9057) :971-977
[10]   Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure -: The metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF) [J].
Hjalmarson, Å ;
Goldstein, S ;
Fagerberg, B ;
Wedel, H ;
Waagstein, F ;
Kjekshus, J ;
Wikstrand, J ;
El Allaf, D ;
Vítovec, J ;
Aldershvile, J ;
Halinen, M ;
Dietz, R ;
Neuhaus, KL ;
Jánosi, A ;
Thorgeirsson, G ;
Dunselman, PHJM ;
Gullestad, L ;
Kuch, J ;
Herlitz, J ;
Rickenbacher, P ;
Ball, S ;
Gottlieb, S ;
Deedwania, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (10) :1295-1302